Results 71 to 80 of about 105,578,950 (193)
The concentrations of plasma a-2-AP and PAI-1 in the patients with OSA and the control group.
The concentrations of alpha-2-antiplasmin and PAI-1 in peripheral blood plasma were determined by enzyme-linked immunosorbent assay (ELISA) in 45 OSA patients and 19 controls. (A) and (B) The concentrations of plasma a-2-AP and PAI-1 in the patients with
Jolanta Pastryk (3353465) +8 more
core +1 more source
Clotting alterations in primary systemic amyloidosis
BACKGROUND AND OBJECTIVE: The bleeding manifestations frequently observed in patients with immunoglobulin light chain amyloidosis (AL) have been attributed to different pathogenetic factors: amyloid deposits in several organs and systems leading to ...
G Gamba +6 more
doaj
Alpha Kappa Alpha EAF Awards luncheon program, July 15, 2014
This program for the Educational Advancement Foundation (EAF) Awards luncheon given by the Alpha Kappa Alpha sorority notes the sequence of events, leaders of the EAF, and sponsors for the gathering.Archival master image scanned in reflective mode as 48 ...
Alpha Kappa Alpha
core +1 more source
Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme
When streptokinase-activated, urokinase-activated, or spontaneously activated human plasmin is mixed with increasing amounts of human antiplasmin, caseinolytic effect decreases much more rapidly than fibrinolytic effect. At concentrations of antiplasmin
Clara M. Ambrus, Gabor Markus
core +1 more source
The plasmin-antiplasmin system: structural and functional aspects [PDF]
The plasmin-antiplasmin system plays a key role in blood coagulation and fibrinolysis. Plasmin and α2-antiplasmin are primarily responsible for a controlled and regulated dissolution of the fibrin polymers into soluble fragments. However, besides plasmin(
Gerber, Simon, Schaller, Johann
core
Background: Rare coagulation factor deficiencies and disorders of fibrinolysis (defined as rare bleeding disorders [RBDs]) present with a heterogeneous bleeding phenotype, and bleeding severity is difficult to predict.
Sterre P.E. Willems +15 more
doaj +1 more source
To delineate the role of plasmin inhibitors, especially the two molecular forms of α2-antiplasmin (that is, the plasminogen-binding and the nonplasminogen-binding forms), in the control of systemic effects during thrombolytic therapy, the consumption of ...
Knot, E.A.R. +5 more
core
Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction
Alpha-2-antiplasmin (alpha 2AP) undergoes both N- and C-terminal cleavages, which significantly modify its activities. Compared with other Ser protease inhibitors (serpins), alpha 2AP contains an similar to 50-residue-extended C-terminus, which binds ...
Lisman, T. +23 more
core +1 more source
Haemostatic Parameters in Patients with Behçet’s Disease
Objectives: This study aimed to evaluate the cause of thrombosis in Behçet’s disease (BD) patients, since abnormalities in coagulation and fibrinolytic parameters have shown contradictory results.
Juma K. Alkaabi +3 more
doaj +2 more sources
Carbon Monoxide and Nitric Oxide Induced-Heme-Based Modification of Alpha-2-Antiplasmin and Plasmin Activity [PDF]
Objectives: Carbon monoxide (CO) derived from cigarette smoke or released from carbon monoxide releasing-molecule 2 (CORM-2), diminishes fibrinolysis. The primary purpose of this study was to determine if CO diminished fibrinolysis by means of enhancing ...
Arkebauer, Matthew R.
core

